Tilki D - Search Results

1

Impact of prostate volume on oncologic, perioperative, and functional outcomes after radical prostatectomy.

Mandel P, Weinhold P, Michl U, Huland H, Graefen M, Tilki D. Mandel P, et al. Among authors: tilki d. Prostate. 2015 Sep;75(13):1436-46. doi: 10.1002/pros.23023. Epub 2015 Jun 12. Prostate. 2015. PMID: 26074139

2

Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer.

Oliveira-Ferrer L, Tilki D, Ziegeler G, Hauschild J, Loges S, Irmak S, Kilic E, Huland H, Friedrich M, Ergün S. Oliveira-Ferrer L, et al. Among authors: tilki d. Cancer Res. 2004 Dec 15;64(24):8932-8. doi: 10.1158/0008-5472.CAN-04-0505. Cancer Res. 2004. PMID: 15604255

3

Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer.

Irmak S, Tilki D, Heukeshoven J, Oliveira-Ferrer L, Friedrich M, Huland H, Ergün S. Irmak S, et al. Among authors: tilki d. Proteomics. 2005 Nov;5(16):4296-304. doi: 10.1002/pmic.200402005. Proteomics. 2005. PMID: 16196100

4

CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer.

Tilki D, Irmak S, Oliveira-Ferrer L, Hauschild J, Miethe K, Atakaya H, Hammerer P, Friedrich MG, Schuch G, Galalae R, Stief CG, Kilic E, Huland H, Ergun S. Tilki D, et al. Oncogene. 2006 Aug 17;25(36):4965-74. doi: 10.1038/sj.onc.1209514. Epub 2006 Mar 27. Oncogene. 2006. PMID: 16568082

5

Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.

Tilki D, Schlenker B, John M, Buchner A, Stanislaus P, Gratzke C, Karl A, Tan GY, Ergün S, Tewari AK, Stief CG, Seitz M, Reich O. Tilki D, et al. Urol Oncol. 2011 Sep-Oct;29(5):508-14. doi: 10.1016/j.urolonc.2009.07.003. Epub 2009 Oct 17. Urol Oncol. 2011. PMID: 19837614 Clinical Trial.

6

Minimizing complications during retropubic radical prostatectomy - Is ureteral stenting necessary?

Schlenker B, Gratzke C, Seitz M, von Walter P, Tilki D, Reich O, Zaak D, Stief CG, Bader MJ. Schlenker B, et al. Among authors: tilki d. Eur J Med Res. 2010 Mar 30;15(3):121-3. doi: 10.1186/2047-783x-15-3-121. Eur J Med Res. 2010. PMID: 20452897 Free PMC article.

7

18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.

Tilki D, Reich O, Graser A, Hacker M, Silchinger J, Becker AJ, Khoder W, Bartenstein P, Stief CG, Loidl W, Seitz M. Tilki D, et al. Eur Urol. 2013 May;63(5):792-6. doi: 10.1016/j.eururo.2012.08.003. Epub 2012 Aug 10. Eur Urol. 2013. PMID: 22902037

8

Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.

Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. Tilki D, et al. Eur Urol. 2014 Sep;66(3):577-83. doi: 10.1016/j.eururo.2013.06.048. Epub 2013 Jul 10. Eur Urol. 2014. PMID: 23871402

9

EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer.

May M, Burger M, Brookman-May S, Stief CG, Fritsche HM, Roigas J, Zacharias M, Bader M, Mandel P, Gilfrich C, Seitz M, Tilki D. May M, et al. Among authors: tilki d. Clin Genitourin Cancer. 2014 Aug;12(4):278-86. doi: 10.1016/j.clgc.2013.11.014. Epub 2013 Nov 13. Clin Genitourin Cancer. 2014. PMID: 24331576

10

The effect of BMI on clinicopathologic and functional outcomes after open radical prostatectomy.

Mandel P, Kretschmer A, Chandrasekar T, Nguyen HG, Buchner A, Stief CG, Tilki D. Mandel P, et al. Among authors: tilki d. Urol Oncol. 2014 Apr;32(3):297-302. doi: 10.1016/j.urolonc.2013.09.005. Epub 2013 Dec 12. Urol Oncol. 2014. PMID: 24332640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

567 results

Search Page